Impaired ATP kinetics in failing in vivo mouse heart

Circulation: Cardiovascular Imaging

Volumn 4, Issue 1, 2011, Pages 42-50

  Gupta, Ashish ^a   Chacko, Vadappuram P ^a   Schär, Michael ^a,b   Akki, Ashwin ^a   Weiss, Robert G ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Phillips Healthcare   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

CK flux; Energetics; Hypertrophy; In vivo mouse hearts; Magnetic resonance spectroscopy

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; HEART FAILURE; HEART RATE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SKELETAL MUSCLE; THORACIC AORTA; ANIMAL; DISEASE MODEL; HEART MUSCLE; KINETICS; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADENOSINE TRIPHOSPHATE; ANIMALS; CREATINE KINASE; DISEASE MODELS, ANIMAL; HEART FAILURE; KINETICS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MYOCARDIUM;

EID: 79952175821     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.110.959320     Document Type: Article

References (42)

1. Katz AM. Is the failing heart energy depleted? Cardiol Clin. 1998;16: 633-644. (Pubitemid 28509447)
2. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res. 2004;95:135-145. (Pubitemid 38988679)
3. Chacko VP, Aresta F, Chacko SM, Weiss RG. MRI/MRS assessment of in vivo murine cardiac metabolism, morphology and function at physiological heart rates. Am J Physiol Heart Circ Physiol. 2000;279: H2218-H2224.
4. Maslov MY, Chacko VP, Stuber M, Moens AL, Kass DA, Champion HC, Weiss RG. Altered high energy phosphate metabolism predicts contractile dysfunction and subsequent ventricular remodeling in pressure overload hypertrophy mice. Am J Physiol Heart Circ Physiol. 2007;292:H387-H391. (Pubitemid 46105201)
5. 31P magnetic resonance spectroscopy. Lancet. 1991;338:973-976.
6. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J. 1991;122:795- 801.
7. 31P SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol. 2002;40:1267-1274.
8. Weiss RG, Gerstenblith G, Bottomley PA. ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A. 2005;102:808-813. (Pubitemid 40282747)
9. Smith CS, Bottomley PA, Schulman SP, Gerstenblith G, Weiss RG. Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation. 2006;114:1151-1158. (Pubitemid 44386479)
10. 31P spectroscopy for measuring human creatine kinase reaction kinetics. Magn Reson Med. 2010;63:1493-1501.
11. Saupe KW, Spindler M, Tian R, Ingwall JS. Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. Circ Res. 1998;82:898 -907. (Pubitemid 28234581)
12. Saupe WK, Spindler M, Hopkins CAJ, Shen W, Ingwall JS. Kinetic thermodynamic and developmental consequences of deleting creatine kinase isoenzymes from the heart. J Biol Chem. 2000;275:19742-19746.
13. Hove MT, Lygate CA, Fischer A, Schneider JE, Sang AE, Hulbert K, Montefiore LS, Watkins H, Clarke K, Isbrandt D, Wallis J, Neubauer S. Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-deficient guanidinoacetate-Nmethyltransferase- knockout mice. Circulation. 2005;111:2477-2485. (Pubitemid 40696136)
14. Pinz I, Ostroy SE, Hoyer K, Osinska H, Robbins J, Molkentin JD, Ingwall JS. Clacineurin-induced energy wasting in a transgenic mouse model of heart failure. Am J Physiol Heart Circ Physiol. 2008;294:H1459-H1466. (Pubitemid 351468746)
15. Gupta A, Chacko VP, Weiss RG. Abnormal energetics and ATP depletion in pressure-overload mouse hearts: in vivo high-energy phosphate concentration measures by noninvasive magnetic resonance. Am J Physiol Heart Circ Physiol. 2009;297:H59-H64.
16. Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguer ER, Bedja D, Gabrielson KL, Wang Y, Kass DA. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med. 2005;11:214 -222. (Pubitemid 40321358)
17. 31P NMR data [abstract]. Soc Magn Reson Med. 1990;9:1089.
18. Bottomley PA, Hardy CJ, Roemer PB, Weiss RG. Problems and expediencies in human 31P spectroscopy: the definition of localized volumes, dealing with saturation and technique-dependence of quantification. NMR Biomed. 1989;20:284 -289.
19. El-Sharkawy AM, Schär M, Ouwerkerk R, Weiss RG, Bottomley PA. Quantitative cardiac 31P spectroscopy at 3T using adiabatic pulses. Magn Reson Med. 2009;61:785-795.
20. Lowry O, Rosebrough N, Farr A, Randall R. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
21. Oliver IT. A spectrophotometric method for the determination of creatine phosphokinase and myokinase. Biochem J. 1955;61:116 -122.
22. Bottomley PA, Ouwerkerk R, Lee RF, Weiss RG. Four-angle saturation transfer (FAST) method for measuring creatine kinase rates in vivo. Magn Reson Med. 2002;47:850-863.
23. Portman MA, Ning XH. Maturational changes in respiratory control through creatine kinase in heart in vivo. Am J Physiol Cell Physiol. 1992;263:C453-C460.
24. Katz LA, Swain JA, Portman MA. Relation between phosphate metabolites and oxygen consumption of heart in vivo. Am J Physiol Heart Circ Physiol. 1989;256:H265-H274.
25. Wallimann T, Wyss M, Brdiczka D, Nicolayt K, Eppenberger HM. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J. 1992;281:21- 40.
26. Wallimann T. Dissecting the role of creatine kinase. Curr Biol. 1994;4: 42-46. (Pubitemid 124001163)
27. Ingwall JS, Kramer MF, Fifer MA, Lorell BH, Shemin R, Grossman W, Allen PD. The creatine kinase system in normal and diseased human myocardium. N Engl J Med. 1985;313:1050 -1054. (Pubitemid 16243332)
28. Shen W, Assai K, Uechi M, Mathier MA, Shannon RP, Vatner SF, Ingwall JS. Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs. Circulation. 1999;100:2113-2118. (Pubitemid 29532064)
29. Flogel U, Decking UKM, Godecke A, Schrader J. Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: a study in endothelial NO synthase knockout mice. J Mol Cell Cardiol. 1999;31: 827-836. (Pubitemid 29201552)
30. Bessman SP, Carpenter CL. The creatine-creatine phosphate energy shuttle. Annu Rev Biochem. 1985;54:831- 862. (Pubitemid 15073666)
31. Dzeja PP, Terzic A. Phosphotransfer networks and cellular energetics. J Exp Biol. 2003;206(Pt 12):2039 -2047. (Pubitemid 36761807)
32. Ventura-Clapier R, Garnier A, Veksler V. Energy metabolism in heart failure. J Physiol. 2004;15:555(Pt 1):1-13. (Pubitemid 38313058)
33. Ingwal JS. Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscles. Am J Physiol. 1982;242:H729-H744.
34. Xiong Q, Li Q, Mansoor A, Jameel MN, Du F, Chen W, Zhang J. Novel strategy for measuring creatine kinase reaction rate in the in vivo heart. Am J Physiol Heart Circ Physiol. 2009;297:H1010-H1019.
35. Peterson LR, Herrero P, McGill J, Schechtman KB, Ware ZK, Lesniak D, Gropler RJ. Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes. Diabetes. 2008;57:32- 40.
36. Ye Y, Wang C, Zhang J, Cho YK, Gong G, Murakami Y, Bache RJ. Myocardial creatine kinase kinetics and isoform expression in hearts with severe LV hypertrophy. Am J Physiol Heart Circ Physiol. 2001;281: H376-H386.
37. Ye Y, Gong G, Ochiai K, Liu J, Zhang J. High energy phosphate metabolism and creatine kinase in failing hearts: a new porcine model. Circulation. 2001;103:1570 -1576. (Pubitemid 32226267)
38. Bache RJ, Zhang J, Murakami Y, Zhang Y, Cho YK, Merkle H, Gong G, From AHL, Ugurbil K. Myocardial oxygenation at high workstates in hearts with left ventricular hypertrophy. Cardiovasc Res. 1999;42: 616-626. (Pubitemid 29298130)
39. Monroe RG. Myocardial oxygen consumption during ventricular concentration and relaxation. Circ Res. 1964;14:294 -300.
40. 31P nuclear magnetic resonance. Proc Natl Acad Sci U S A. 1980;77: 3654 -3658. (Pubitemid 10012916)
41. Chung Y, Sharman R, Carlsen R, Unger SW, Larson D, Jue T. Metabolic fluctuation during a muscle contraction cycle. Am J Physiol. 1998;274: C846-C852.
42. 31P NMR Detection of subcellular creatine kinase fluxes in the perfused rat heart; contractility modifies energy transfer pathways. J Biol Chem. 2002;277:18469-18476. (Pubitemid 34952394)